These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35406095)
21. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis. Seo DS; Chau GC; Baek KH; Um SH Mol Metab; 2019 Mar; 21():82-89. PubMed ID: 30583978 [TBL] [Abstract][Full Text] [Related]
22. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Kendrick AA; Choudhury M; Rahman SM; McCurdy CE; Friederich M; Van Hove JL; Watson PA; Birdsey N; Bao J; Gius D; Sack MN; Jing E; Kahn CR; Friedman JE; Jonscher KR Biochem J; 2011 Feb; 433(3):505-14. PubMed ID: 21044047 [TBL] [Abstract][Full Text] [Related]
23. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice. Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289 [TBL] [Abstract][Full Text] [Related]
24. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Yang ZH; Miyahara H; Hatanaka A Lipids Health Dis; 2011 Jul; 10():120. PubMed ID: 21774832 [TBL] [Abstract][Full Text] [Related]
26. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice. Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728 [TBL] [Abstract][Full Text] [Related]
27. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase. Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967 [No Abstract] [Full Text] [Related]
29. Prostaglandin F Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555 [TBL] [Abstract][Full Text] [Related]
30. EP Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059 [TBL] [Abstract][Full Text] [Related]
32. NFIL3 is a negative regulator of hepatic gluconeogenesis. Kang G; Han HS; Koo SH Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537 [TBL] [Abstract][Full Text] [Related]
33. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway. Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. Li X; Xu M; Wang F; Kohan AB; Haas MK; Yang Q; Lou D; Obici S; Davidson WS; Tso P J Biol Chem; 2014 Jan; 289(4):2396-404. PubMed ID: 24311788 [TBL] [Abstract][Full Text] [Related]
36. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Zhang T; Liu J; Shen S; Tong Q; Ma X; Lin L Cell Death Differ; 2020 Jan; 27(1):329-344. PubMed ID: 31160717 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis. Chang JS; Jun HJ; Park M Physiol Rep; 2016 Oct; 4(20):. PubMed ID: 27798359 [TBL] [Abstract][Full Text] [Related]